Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M179Revenue $M5.7Net Margin (%)-750.0Z-Score-15.4
Enterprise Value $M141EPS $-0.8Operating Margin %-785.5F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-750.0Higher ROA y-yN
Price/Book13.010-y EBITDA Growth Rate %-38.0Quick Ratio1.6Cash flow > EarningsN
Price/Sales28.35-y EBITDA Growth Rate %-21.9Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-82.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-406.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M67.7ROI % (ttm)-267.8Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSJean-Marie Eveillard 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 2.6422%New holding1,414,276
SNSSJean-Marie Eveillard 2014-09-30 Sold Out $5.553 - $8.23
($6.91)
$ 2.64-162%Sold Out0
SNSSJean-Marie Eveillard 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 2.64-92%New holding200,000
SNSSJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 2.64-97%Sold Out0
SNSSJean-Marie Eveillard 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 2.64-34%Reduce -30.24%350,000
SNSSJean-Marie Eveillard 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 2.64-5%New holding501,727
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-64.24view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-64.24view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-64.24view
SANDELL SCOTT D10% Owner 2014-08-29Sell266,700$7.97-64.24view
KOLLURI KRISHNA KITTU10% Owner 2014-08-29Sell266,700$7.97-64.24view
KERINS PATRICK J10% Owner 2014-08-29Sell266,700$7.97-64.24view
DRANT RYAN D10% Owner 2014-08-29Sell266,700$7.97-64.24view
BASKETT FOREST10% Owner 2014-08-29Sell266,700$7.97-64.24view
Misfeldt DaytonDirector, 10% Owner 2014-08-28Sell300,700$7.98-64.29view
BAY CITY CAPITAL LLC10% Owner 2014-08-28Sell300,700$7.98-64.29view

Press Releases about SNSS :

    Quarterly/Annual Reports about SNSS:

    News about SNSS:

    Articles On GuruFocus.com
    ciazek stock Mar 28 2015 
    comment on SNSS Mar 02 2013 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 10 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
    cooldecency99 note on SNSS May 01 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
    Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
    Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 

    More From Other Websites
    Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind Apr 10 2015
    Sunesis Pharmaceuticals Inc.'s CEO Daniel Swisher Interviewed by The Life Sciences Report Apr 02 2015
    Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s... Mar 31 2015
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 23 2015
    SUNESIS PHARMACEUTICALS INC Financials Mar 19 2015
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 12 2015
    Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today Mar 12 2015
    Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent... Mar 12 2015
    Sunesis reports 4Q loss Mar 12 2015
    Sunesis reports 4Q loss Mar 12 2015
    Q4 2014 Sunesis Pharmaceuticals Inc Earnings Release - Before Market Open Mar 12 2015
    Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent... Mar 12 2015
    Sunesis to Host Conference Call on March 12th to Discuss Fourth Quarter and Full-Year 2014 Financial... Mar 05 2015
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Mar 02 2015
    Sunesis Announces Amendment to Loan Agreement Mar 02 2015
    Sunesis Announces Amendment to Loan Agreement Mar 02 2015
    Sunesis to Present at Upcoming Investor Conferences Feb 24 2015
    Sunesis to Present at Upcoming Investor Conferences Feb 24 2015
    Sunesis to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Feb 18 2015
    Sunesis to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK